Athira Pharma, Inc. insider trading activity
Understanding Insider Activity at Athira Pharma, Inc.
Welcome to our dedicated page for Athira Pharma, Inc. (Nasdaq: ATHA) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Athira Pharma, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Athira Pharma, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for ATHATicker | Time & Date | Filing | Link |
---|---|---|---|
ATHA | 11:51:04 PM 9/5/2024 | Gengos Andrew(CFO and Chief Business Officer) sold 1272 shares of Athira Pharma, Inc. (ATHA) for ~$725 | Filing |
ATHA | 11:50:23 PM 9/5/2024 | Lenington Rachel(COO and CDO) sold 2525 shares of Athira Pharma, Inc. (ATHA) for ~$1439 | Filing |
ATHA | 11:49:11 PM 9/5/2024 | CHURCH KEVIN(CHIEF SCIENTIFIC OFFICER) sold 2525 shares of Athira Pharma, Inc. (ATHA) for ~$1439 | Filing |
ATHA | 11:48:21 PM 9/5/2024 | Worthington Mark(GENERAL COUNSEL) sold 2525 shares of Athira Pharma, Inc. (ATHA) for ~$1439 | Filing |
ATHA | 11:47:27 PM 9/5/2024 | Litton Mark James(President and CEO) sold 5032 shares of Athira Pharma, Inc. (ATHA) for ~$2868 | Filing |
ATHA | 11:21:55 PM, 6/25/2024 | Romano Kelly A purchased 42400 shares of Athira Pharma, Inc. (ATHA) for ~$100208 | Filing |
ATHA | 9:40:35 PM 2/16/2024 | Lenington Rachel(COO AND CDO) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 9:38:45 PM 2/16/2024 | Litton Mark James(CEO) sold 4820 shares of Athira Pharma, Inc. (ATHA) for ~$14026 | Filing |
ATHA | 9:37:00 PM 2/16/2024 | Worthington Mark(GENERAL COUNSEL) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 9:34:18 PM 2/16/2024 | Gengos Andrew(CFO AND CHIEF BUSINESS OFFICER) sold 1208 shares of Athira Pharma, Inc. (ATHA) for ~$3515 | Filing |
ATHA | 9:32:12 PM 2/16/2024 | CHURCH KEVIN(CHIEF SCIENTIFIC OFFICER) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 9:42:49 PM 1/8/2024 | Gengos Andrew(See Below) sold 1208 shares of Athira Pharma, Inc. (ATHA) for ~$3515 | Filing |
ATHA | 9:40:49 PM 1/8/2024 | Litton Mark James(Chief Executive Officer) sold 4820 shares of Athira Pharma, Inc. (ATHA) for ~$14026 | Filing |
ATHA | 9:38:45 PM 1/8/2024 | Worthington Mark(General Counsel) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 9:36:44 PM 1/8/2024 | CHURCH KEVIN(Chief Scientific Officer) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 9:35:00 PM 1/8/2024 | Lenington Rachel(Chief Operating Officer) sold 2412 shares of Athira Pharma, Inc. (ATHA) for ~$7018 | Filing |
ATHA | 10:24:55 PM, 12/29/2023 | PERCEPTIVE ADVISORS LLC purchased 605686 shares of Athira Pharma, Inc. (ATHA) for ~$1462894 | Filing |
ATHA | 9:06:28 PM, 6/9/2023 | Gengos Andrew(See Below) purchased 15000 shares of Athira Pharma, Inc. (ATHA) for ~$51450 | Filing |
ATHA | 11:36:20 PM, 6/6/2023 | Gengos Andrew(See Below) purchased 65012 shares of Athira Pharma, Inc. (ATHA) for ~$191605 | Filing |
ATHA | 8:36:50 PM, 3/31/2023 | PICKERING GRANT purchased 25000 shares of Athira Pharma, Inc. (ATHA) for ~$60350 | Filing |
ATHA | 10:59:29 PM, 3/30/2023 | JOHNSON JAMES A purchased 5000 shares of Athira Pharma, Inc. (ATHA) for ~$12000 | Filing |
ATHA | 9:58:16 PM, 12/30/2022 | MILESON GLENNA(Chief Financial Officer) purchased 50000 shares of Athira Pharma, Inc. (ATHA) for ~$142500 | Filing |
ATHA | 1:31:29 AM, 12/7/2022 | Romano Kelly A purchased 30000 shares of Athira Pharma, Inc. (ATHA) for ~$98700 | Filing |
ATHA | 12:10:32 AM, 11/18/2022 | MOEBIUS HANS(Chief Medical Officer) purchased 5000 shares of Athira Pharma, Inc. (ATHA) for ~$16450 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 24 insider filings.
Register now to dive deeper and explore the full dataset.